Skip to main content
. 2013 Mar 12;168(7):1531–1554. doi: 10.1111/bph.12052

Table 2.

Effects of antidepressants in patients with epilepsy

Study group Antidepressants Follow up Seizure frequency in treatment group Reference
9 PWE FLX 3 months 4 Px increase in seizure frequency by >50%; 5 Px not increased Gigli et al. (1994)
36 PWE and MDD SRT, FLX 1 year 2 Px increase in seizure frequency; 34 Px not increased (number of Px with reduced seizures not mentioned) Thome-Souza et al. (2007)
100 PWE and depression or OCD SRT 1 year 6 Px increase in seizure frequency; 94 Px not increased (number of Px with reduced seizures not mentioned) Kanner et al. (2000)
39 PWE and depression CIT 4 months 2 Px had 50% increase in seizures; 37 Px with 50% decrease in seizures Specchio et al. (2004)
11 PWE CIT 8–10 months All Px showed improvements: 64.1% mean reduction in seizure frequency Favale et al. (2003)
17 PWE FLX 14 months Seizures disappeared in 6 Px; in others, seizure frequency reduced by 30% Favale et al. (1995)
43 PWE and HAMD score >15 CIT 2 months No change in seizure frequency Hovorka et al. (2000)
75 PWE and HAMD score >15 MIR, CIT, REB 7.5 months No change in seizure frequency Kuhn et al. (2003)
28 PWE FLV 29–444 days No change in seizure frequency Harmant et al. (1990)
121 PWE Various 1st and 2nd gen. drugs 1 year No change in seizure frequency compared to non-treated Px Okazaki et al. (2011)

Patient drop outs not included in sample sizes.

CIT, citalopram; FLV, fluvoxamine; FLX, fluoxetine; HAMD, hamilton depression rating scale; MDD, major depressive disorder; MIR, mirtazepine; OCD, obsessive compulsive disorder; PWE, people with epilepsy; Px, patients; REB, reboxetine; SRT, sertraline.